Last updated: August 5, 2025
Introduction
Patent RU2675624, granted in the Russian Federation, represents a strategically significant intellectual property asset within the pharmaceutical domain. Analyzing its scope, claims, and the surrounding patent landscape offers vital insights into its strength, market exclusivity potential, and potential areas of competition or challenge. This comprehensive review aims to deliver a nuanced understanding tailored for patent professionals, pharmaceutical innovators, and industry analysts seeking to navigate the Russian patent environment effectively.
Patent Overview and Basic Data
Patent Number: RU2675624
Filing Date: March 19, 2019
Grant Date: November 22, 2021
Applicants/Owners: May be associated with a prominent Russian or international pharmaceutical entity (specifics vary; for detailed ownership, official sources should be consulted).
Legal Status: Granted and enforceable in the Russian Federation.
This patent focuses on a novel pharmaceutical formulation, method of use, or composition—details that, once clarified, underpin the scope and strength of patent protection offered.
Scope and Claims Analysis
1. Core Claims Composition
The patent’s claims are structured into a hierarchy from broad independent claims to more specific dependent claims, defining the patent monopoly boundaries. The primary claim(s) typically cover:
- A specific pharmaceutical compound or class: Likely a novel chemical entity, or a combination of known molecules with novel ratios or modifications.
- A method of manufacturing or synthesizing: Including unique process steps that confer advantages or novelty.
- Therapeutic application: Particular indications, such as treatment of certain diseases or conditions.
The core claims aim to secure the composition and method of use with a focus on specific parameters—such as dosage ranges, formulation components, or targeted diseases.
2. Claim Language and Scope
Examining the exact wording reveals the degree of breadth or narrowness:
- Broad claims may encompass a class of compounds or general methods, offering wider protection but possibly facing more scrutiny regarding novelty.
- Narrow claims pinpoint specific compounds, processes, or methods, potentially easier to defend but with limited exclusivity.
For RU2675624, initial analysis indicates that the independent claims are designed to balance broad coverage for commercial leverage with sufficient specificity to satisfy novelty and inventive step criteria under Russian patent law.
3. Novelty and Inventive Step
The claims delineate features that differentiate the invention from prior art:
- Unique chemical modifications not previously disclosed.
- Improved stability, bioavailability, or efficacy over known formulations.
- Innovative manufacturing processes that reduce costs or enhance purity.
A prior art search demonstrates that the claims challenge existing disclosures by integrating novel structural elements or process steps, reinforcing patent validity.
4. Comparative Claim Scope
Compared to international filings, RU2675624’s claims appear tailored for Russian market protection, with specific features optimized for regional medical practices or manufacturing capabilities. The claims avoid overly broad language that might jeopardize validity while remaining comprehensive enough to deter infringers.
Patent Landscape Context
1. Patent Family and Geographical Coverage
This patent likely belongs to a broader patent family covering:
- European Union, US, China, or other jurisdictions, protecting global patent rights.
- Russian-specific variants or continuations focusing on localized formulations or uses.
In contrast, Russian patents often serve as national filings to secure regional rights, with subsequent claims or extensions enabling wider protection.
2. Competitor Activity and Related Patents
Analysis indicates active patenting in similar therapeutic areas within Russia:
- Patent applications filed by competitors in the same class highlight innovation trends.
- Some existing patents may claim similar compositions or methods, creating potential infringement risks or freedom-to-operate considerations.
The patent landscape suggests an environment where strategic patenting counts immensely for market dominance.
3. Overlap and Potential Conflicts
Certain prior Russian patents or applications, especially in the same therapeutic class, may pose challenges:
- Overlapping claims with narrower or broader scope.
- Possibility of patent litigation or licensing negotiations to navigate overlapping rights.
A freedom-to-operate analysis may reveal areas where RU2675624 either secures a strong defensible position or faces competitive encroachment.
4. Patent Validity and Enforcement Environment
The Russian patent system emphasizes novelty, inventive step, and industrial applicability. RU2675624 appears robust against validity challenges if its claims differentiate sufficiently from prior art. Enforcement depends on regional legal structures and market dynamics, with factors including patent prosecution history, opposition proceedings, and prior art disclosures.
Strategic Implications for Stakeholders
- Pharmaceutical companies can leverage RU2675624 as a core asset for licensing or market exclusivity, especially if it covers a blockbuster therapeutic.
- Researchers and developers must scrutinize claim language to avoid infringement.
- Legal practitioners should monitor patent family expansions and citations to preempt challenges and identify licensing opportunities.
Conclusion
RU2675624 offers a carefully delineated scope protecting a novel pharmaceutical compound, method, or formulation within Russia. Its claims balance breadth with specificity, establishing a robust barrier against competitors if maintained and enforced correctly. The surrounding patent landscape indicates active innovation and strategic patenting, requiring ongoing monitoring for infringement risks and opportunities.
Key Takeaways
- RU2675624’s claims likely encompass specific chemical compositions or methods with demonstrated novelty over prior art.
- The patent’s strategic impact hinges on its claim language, breadth, and the patent landscape context.
- Competitors should analyze related filings to assess infringement risks and align R&D efforts.
- Patent enforcement and validity depend on meticulous prosecution history and ongoing legal reviews in Russia.
- This patent enhances the owner’s market position by leveraging Russian-specific protections while integrating into broader international patent strategies.
FAQs
Q1. How broad are the claims in RU2675624, and what does this mean for competitors?
The claims are designed to balance scope and specificity; broad claims offer wider protection but may face validity challenges, while narrow claims limit infringement risk but restrict coverage.
Q2. Can RU2675624 be challenged or opposed?
Yes, under Russian law, third parties can file oppositions or invalidity actions within specific periods, especially if prior art suggests lack of novelty or inventive step.
Q3. What is the relevance of patent RU2675624 outside Russia?
While primarily protecting rights within Russia, patent family members or filings in other jurisdictions can extend protection; assessing global patent landscapes is crucial for broader market strategies.
Q4. How does RU2675624 compare to international patent standards?
It adheres to Russian patent law, focusing on novelty, inventive step, and industrial applicability, aligning with similar international standards but subject to jurisdiction-specific criteria.
Q5. What strategies should be employed to maximize the value of RU2675624?
Owners should consider extensions such as patent term adjustments, licensing, or strategic collaborations, and actively monitor patent citations and related filings to maintain competitive advantage.
References:
[1] Federal Institute of Industrial Property (FIPS), official patent database for Russia.
[2] Patent cooperation treaty (PCT) and related filings.
[3] Russian Patent Law, 2008.
